Transition To Private Coverage Of COVID-19 Products Tied To Fate Of Pandemic Relief Bill

By John Wilkerson / May 23, 2022 at 5:01 PM
The Senate is in session this week, but House lawmakers are on recess for two weeks so pandemic relief must wait until their return. A lot rides on the fate of coronavirus relief because, without it, coverage of coronavirus vaccines and therapeutics will likely shift to private insurance, and that could lead to higher prices and would change how doctors and pharmacists are paid to prescribe and administer those products. The pandemic supplemental funding bill, which is now at $10...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.